Clinical trial · Interventional
The Effects of Sufentanil vs. Remifentanil in Total Intravenous Anesthesia With Remimazolam on Postoperative Pain
The Effects of Sufentanil-remimazolam vs. Remifentanil-remimazolam Total Intravenous Anesthesia on Postoperative Pain in Laparoscopic-assisted Gastrectomy - A Randomized, Controlled Study-
NCT05785234CI-TRIAL-00065036unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
In this study, the investigators evaluate the effect of total intravenous anesthesia using sufentanil-remimazolam and remifentanil-remimazolam on postoperative pain in patients undergoing laparoscopic gastrectomy.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Stomach Neoplasms | Gastric Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| remifentanil-remimazolam group | Drug | — | UNRESOLVED |
| sufentanil-remimazolam group | Drug | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Sufentanil-remimazolam group
- description
- The sufentanil-remimazolam group receives total intravenous anesthesia with sufentanil-remimazolam.
- interventionNames
- Drug: sufentanil-remimazolam group
- type
- ACTIVE_COMPARATOR
- label
- Remifentanil-remimazolam group
- description
- The remifentanil-remimazolam group receives total intravenous anesthesia with remifentanil-remimazolam.
- interventionNames
- Drug: remifentanil-remimazolam group
Primary outcomes (1)
- measure
- Total consumption of fentanyl in 24 hours after surgery
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
Show eligibility criteria text
Inclusion Criteria: 1. 20years or older 2. Scheduled for laparoscopic-assisted gastrectomy 3. American Society of Anesthesiologists(ASA) physical status I and III Exclusion Criteria: 1. Emergency operation 2. Patients with a history of severe hypersensitivity reaction to dextran 40 3. Patients who cannot use patient controlled analgesia(PCA) 4. Patients with morbid obesity \[body mass index (BMI) \>35 kg/m2\] 5. Patients with history of uncontrolled hypertension (diastolic BP \>110mmHg) or DM 6. Patients with history of heart failure (unstable angina, congestive heart failure) 7. Patients with history of liver failure, renal failure, allergic to medicine 8. Patients with history of cerebrovascular disease (cerebral hemorrhage, cerebral ischemia) 9. Patients with history of uncontrolled psychiatric disease (PTSD, anxiety, depression) 10. Patients with obstructive sleep apnea 11. Patients who cannot read the consent form (examples: Illiterate, foreigner) 12. Patients who withdraw the consent
References
Publications (0)
Data not yet available
No reference posted for this study.